|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.95 EUR | -4.37% |
|
-2.76% | -4.68% |
| 01:29pm | Who is Sanofi's new CEO Belén Garijo? | RE |
| 12:48pm | Who is Sanofi's new CEO Belén Garijo? | RE |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 98,877 | 111,194 | 112,665 | 112,549 | 116,968 | 99,802 | 99,802 | - |
| Change | - | 12.46% | 1.32% | -0.1% | 3.93% | -14.68% | 0% | - |
| Enterprise Value (EV) 1 | 107,666 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 109,550 | 105,767 |
| Change | - | 12.55% | -1.71% | 1.04% | 4.49% | -11.2% | -2.22% | -3.45% |
| P/E ratio | 8.01x | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 12.5x | 11.3x |
| PBR | 1.57x | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.27x | 1.2x |
| PEG | - | -0.4x | 2.07x | -1.1x | 3.14x | 0.3x | -9.7x | 1.14x |
| Capitalization / Revenue | 2.74x | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 2.15x | 2.02x |
| EV / Revenue | 2.99x | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.36x | 2.14x |
| EV / EBITDA | 9.41x | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 7.81x | 7.11x |
| EV / EBIT | 11x | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 8.45x | 7.66x |
| EV / FCF | 15.4x | 15x | 14x | 14.2x | 21.1x | 13.8x | 16.7x | 11.1x |
| FCF Yield | 6.48% | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 5.99% | 8.98% |
| Dividend per Share 2 | 3.2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.211 | 4.512 |
| Rate of return | 4.07% | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.1% | 5.47% |
| EPS 2 | 9.82 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.624 | 7.28 |
| Distribution rate | 32.6% | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 63.6% | 62% |
| Net sales 1 | 36,041 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 46,454 | 49,309 |
| EBITDA 1 | 11,443 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,018 | 14,879 |
| EBIT 1 | 9,762 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 12,965 | 13,814 |
| Net income 1 | 12,314 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 8,428 | 9,174 |
| Net Debt 1 | 8,789 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 9,748 | 5,965 |
| Reference price 2 | 78.70 | 88.58 | 89.84 | 89.76 | 93.74 | 82.56 | 82.56 | 82.56 |
| Nbr of stocks (in thousands) | 1,256,375 | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,208,842 | 1,208,842 | - |
| Announcement Date | 05/02/21 | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.3x | 2.57x | 8.4x | 4.98% | 118B | ||
| 45.03x | 14.66x | 32.51x | 0.58% | 909B | ||
| 21.88x | 6.45x | 17.93x | 2.14% | 580B | ||
| 61.68x | 7.33x | 18.16x | 2.96% | 390B | ||
| 18.46x | 4.66x | 11.57x | 2.82% | 370B | ||
| 21.04x | 5.88x | 14.48x | 2.75% | 305B | ||
| 31.88x | 5.72x | 17.06x | 1.61% | 314B | ||
| 15.41x | 4.95x | 10.8x | 2.71% | 296B | ||
| 14.71x | 5.03x | 10.56x | 3.54% | 216B | ||
| 28.48x | 6.66x | 11.4x | 2.61% | 197B | ||
| Average | 27.09x | 6.39x | 15.28x | 2.67% | 369.58B | |
| Weighted average by Cap. | 31.32x | 7.96x | 18.89x | 2.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















